APA (7th ed.) Citation

Michaeli, D., Michaeli, C. T., Albers, S., & Michaeli, J. (2024). Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations. Journal of the National Cancer Institute, 116(2), . https://doi.org/10.1093/jnci/djad212

Chicago Style (17th ed.) Citation

Michaeli, Daniel, Christoph T. Michaeli, Sebastian Albers, and Julia Michaeli. "Clinical Benefit, Development, Innovation, Trials, Epidemiology, and Price for Cancer Drugs and Indications with Multiple Special FDA Designations." Journal of the National Cancer Institute 116, no. 2 (2024). https://doi.org/10.1093/jnci/djad212.

MLA (9th ed.) Citation

Michaeli, Daniel, et al. "Clinical Benefit, Development, Innovation, Trials, Epidemiology, and Price for Cancer Drugs and Indications with Multiple Special FDA Designations." Journal of the National Cancer Institute, vol. 116, no. 2, 2024, https://doi.org/10.1093/jnci/djad212.